IMUNOFAN - MODERN EFFECTIVE IMMUNOMODULATOR

Imunofan is synthesized on the basis of the natural peptide hormone of the thymus gland - thymopoietin. The drug contains as an active pharmacological substance a peptide representing a chain of six amino acid residues, the composition and sequence of which are protected by RF patent No. 2062096.

Due to the mechanism of action of its prototype, Imunofan is not an immune stimulant, as well as an immunosuppressant. Imunofan has a modulating effect - it returns immunity indicators to the boundaries of reference values. It increases low and reduces the activity of elevated indicators, ensuring the safety of the drug, as well as the effectiveness and balance of the body's immune response.

According to the composition and mechanism of action, there are currently no analogues of Imunofan. Clinical trials and many years of experience in the therapeutic use of the drug confirm that Imunofan is an effective means of correcting the immune status in various disorders.